FDMT

4D MOLECULAR THERAPEUTICS IN

FDMT·35104E100·US·Common Stock·Healthcare - Biotechnology-13D/G

FDMT (4D MOLECULAR THERAPEUTICS IN) is held by 88 institutional investors as of Q1 2026. Largest holders: Janus Henderson Group Ltd. ($48.9M), RA CAPITAL MANAGEMENT, L.P. ($47M), GOLDMAN SACHS GROUP INC ($39.2M). Net institutional sentiment: Mixed.

88
Holders
Avg rating(21 Elite)
$315.5M
Total Value
49% (97)
Fund Consensus
42 buying - 44 selling
FDMTSmart Money Verdict
View all
Held by 88 funds
21 elite
Who's Trading
InsiderKDKirn DavidSell $184KJul 10, 2026
InsiderKDKirn DavidSell $6KJul 10, 2026
InsiderKDKirn DavidSell $548KJul 9, 2026
InsiderBSBizily ScottSell $92KJun 30, 2026
InsiderBSBizily ScottSell $118KJun 23, 2026
InsiderKDKirn DavidSell $1.2MJun 22, 2026
ActivistBLBVF PARTNERS L P/IL10.0%May 15, 2026
ActivistRA Capital Management, L.P.RA Capital Management, L.P.9.9%May 15, 2026
ActivistSTATE STREET CORPORATIONSTATE STREET CORPORATION5.3%May 12, 2026
ActivistJANUS HENDERSON GROUP PLCJANUS HENDERSON GROUP PLC10.3%Apr 7, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
5.2M(+13.2%)$48.9M0.0%-10.79%
33
Decreased
5M(-10.7%)$47M0.5%-27.24%
0
Decreased
4.2M(-2.3%)$39.2M0.0%+128.28%
0
Increased
4.1M(+2.0%)$38.6M0.0%+125.09%
30
Increased
2.7M(+0.7%)$25.2M0.0%-4.61%
29
Increased
1.6M(+30.0%)$14.9M0.0%+56.48%
35
Decreased
1.4M(-11.0%)$13.3M0.0%+230.75%
0
Increased
1.1M(+5.3%)$9.9M0.0%-43.90%
29
Increased
974,173(+17.0%)$9.1M0.0%+131.44%
32
Increased
708,044(+0.5%)$6.6M0.0%+30.48%
27
Increased
578,265(+12.7%)$5.4M0.0%+71.44%
30
Increased
561,805(+253.8%)$5.2M0.0%+63.02%
44
Increased
522,823(+77.3%)$4.9M0.0%+37.10%
41
Unchanged
475,737$4.4M0.0%+62.40%
0
Increased
415,655(+48.7%)$3.6M0.0%+96.98%
37
Decreased
345,410(-48.6%)$3.2M0.0%-32.79%
0
Increased
342,034(+9.0%)$3.2M0.0%-42.30%
29
Decreased
328,379(-7.1%)$3.1M0.0%-41.62%
0
Increased
310,684(+102.9%)$2.9M0.0%+51.80%
42
Decreased
266,147(-44.3%)$2.5M0.0%+186.05%
0

Showing 1-20 of 97

1 / 5

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used